It also slows gastric emptying by delaying the transit of food into the small intestine, helping maintain blood glucose stability and prolong satiety
Currently, there are no FDA-approved generic versions of Ozempic or Wegovy because the active ingredient, semaglutide, is still protected by patents held by the manufacturer
Kennedy Jr, secretary of the Department of Health and Human Services , said that the American public, because of this agreement, will lose 125 million pounds by this time next year. Obesity is a disease of poverty, overwhelmingly, and these drugs have only been available for people who have wealth, Kennedy said
The practical difference that matters most today, though, is regulatory: tirzepatide is an approved medicine you can be prescribed, while retatrutide is still an investigational compound being evaluated in clinical trials
Archived from the original on 21 January 2023